Baycol Lawsuit - Baycol Litigation

On August 21, 2001, attorneys filed with the United States Judicial Panel for Multidistrict Litigation in Washington, D.C. a Motion for the Transfer and Consolidation of all Baycol lawsuits filed in Federal court nationwide.

The purpose of Multidistrict Litigation ("MDL") is to provide centralized management, under a single court's supervision, of pretrial proceedings to insure efficient adjudication of all Baycol actions filed around the nation and to avoid the unnecessary expenditure of time and money in the litigation of common legal and factual issues.

Since the recall on August 8, 2001, more than 90 state and federal lawsuits have been filed against Bayer and other defendants relating to the use of Baycol. As of September 28, 2001, 55 cases were pending in Federal courts, each arising from claims of injuries suffered as a consequence of Baycol. Class action lawsuits have been filed representing Baycol users in every state in the United States and around the world.

In the Baycol lawsuits, the following are potential defendants:

	Bayer A.G.: Bayer A.G. is a global diversified chemical company with its headquarters based in Leverkusen, Germany
	Bayer Corporation: Bayer Corporation is an Indiana corporation, which is a wholly-owned subsidiary of Defendant Bayer A.G., with its principal place of business at 100 Bayer Road, Pittsburgh, PA 15205.
	GlaxoSmithKline plc: GlaxoSmithKline plc is a British corporation headquartered at Glaxo Welcome House, Berkeley Avenue, Greenford, Middlesex, England. GlaxoSmithKline plc has its principal place of business in the United States at One Franklin Plaza, 200 N. 16th Street, Philadelphia, PA.
	SmithKline Beecham Corporation: SmithKline Beecham Corporation is a Pennsylvania corporation, with its principal place of business located at One Franklin Plaza, Philadelphia, PA. SmithKline Beecham corporation is now a wholly-owned subsidiary of GlaxoSmithKline PLC and also conducts pharmaceutical research and development in the United States under the corporate fictitious name GlaxoSmithKline